68-ga-dotanoc
Showing 1 - 1 of 1
Patients With Gastroenteropancreatic Neuroendocrine Tumors Trial in France (68-Ga-DOTANOC)
Completed
- Patients With Gastroenteropancreatic Neuroendocrine Tumors
- 68-Ga-DOTANOC
-
Angers, France
- +4 more
Jan 6, 2022